SCHEMBL13664162

SCHEMBL13664162

Cc1ccc(C(=O)c2nn(-c3ccc(F)cc3)c(N)c2C#N)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
GAA P10253 1/20 0.51
ALDH1A1 P00352 5/20 0.50
MAPT P10636 4/20 0.50
LMNA P02545 4/20 0.50
MAPK14 Q16539 3/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
SRC P12931 1/20 0.42
BRAF P15056 1/20 0.42
KDR P35968 1/20 0.42
UBE2N P61088 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ALOX12 P18054 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CA1 P00915 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664173 0.94 MAPT (0.55) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664163 0.89 MAPT (0.51) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664175 0.89 MAPK14 (0.63) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664179 0.88 MAPT (0.50) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664170 0.88 MAPT (0.50) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664161 0.88 MAPT (0.51) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664177 0.88 MAPT (0.50) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664203 0.88 MAPT (0.50) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664196 0.88 MAPK14 (0.50) MEN1KMT2AGAAALDH1A1MAPT
SCHEMBL13664172 0.88 MAPT (0.64) GAAALDH1A1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists GIPR, GPR119, GLP1R MEN1 3462/4885KMT2A 3722/4885GAA 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.